Drug
Pegol Sihematide
Pegol Sihematide: highest development phase Phase 1, developed by Hansoh Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Hansoh Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| Pegol-sihematide injection NCT02619097 | Phase 1 | Myelodysplastic Syndromes |
Latest
No recent events.
Follow Pegol Sihematide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.